Some individuals experience persistent gastrointestinal side effects or other adverse effects that necessitate dose reduction or medication discontinuation
Our program is accepted by flexible spending accounts (FSA) and/or health savings accounts (HSA)
Your dose schedule should continue exactly as prescribed by your provider, whether you are on a weekly injection or daily oral formulation
Regarding Retatrutide due to additional glucagon component, there could theoretically be additional reactions related to increased blood sugar and liver stress
Medicare Part D began covering Wegovy for cardiovascular risk reduction in early 2026, a major milestone that expanded access for millions of older Americans
A minority of plans (15%) place Wegovy on Tier 4 specialty, which often includes additional requirements: Mandatory specialty pharmacy dispensing (CVS Specialty Pharmacy only) 30-day supply limits (no 90-day fills) Refill-too-soon edits (can't refill before 75% of previous supply is used) The tier placement is set by the employer plan sponsor, not CVS Caremark directly